Gujarat Kidney And Super Speciality Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pragnesh Bharpoda, authorised signatory on behalf of the promoters and promoter group of Gujarat Kidney and Super Speciality Limited, has submitted a declaration to the exchanges pursuant to Regulation 31(4) of SEBI SAST Regulations, 2011. The disclosure covers the financial year 2025-2026 ending 31st March, 2026. The key declaration states that the promoter group has NOT made any encumbrance, directly or indirectly, on their shareholding during this period. This is a routine compliance filing required to be submitted annually by promoters of listed companies.
Positive signal for retail investors as promoters declaring zero encumbrance indicates they have not pledged shares for loans, reducing risk of sudden supply pressure if pledged shares are invoked.